Hosted on MSN1d
Are Wall Street Analysts Predicting Vertex Pharmaceuticals Stock Will Climb or Sink?
With a market cap of $118.7 billion, Vertex Pharmaceuticals Incorporated (VRTX) is a global biotechnology leader specializing ...
The Business Journals24d
Vertex is hoping for 'historic' non-opioid painkiller approval. It might not be a straightforward blockbuster.
Vertex Pharmaceuticals Inc. is known worldwide for its cystic fibrosis medicines. The Boston drugmaker has won approvals for five CF medicines since 2012. But Vertex has long seen its experimental ...
Yahoo Finance10d
Vertex: Q4 Earnings Snapshot
BOSTON (AP) — BOSTON (AP) — Vertex Pharmaceuticals Inc. (VRTX) on Monday reported fourth-quarter profit of $913 million. The Boston-based company said it had net income of $3.50 per share.
Vertex Pharmaceuticals EVP Ourania Tatsis sells $142,547 in stock
BOSTON—Ourania Tatsis, Executive Vice President and Chief Regulatory and Quality Officer at Vertex Pharmaceuticals Inc. (NASDAQ:VRTX), a $116 billion market cap biotech company currently trading near ...